Mumbai, Feb 8: Global pharmaceutical company Wockhardt on Tuesday said that it has received permission from the national regulatory body for pharmaceuticals CDSCO to export up to 100 million doses of Sputnik vaccines. In a regulatory filing, the company said it has received permission from the Central Drugs Standard Control Organization (CDSCO) to export up to 80 million doses of Sputnik Light and up to 20 million doses of Sputnik V Component I vaccine.
“Wockhardt’s bulk vaccine and fill-finish manufacturing facilities at Waluj and Shendra, Aurangabad, respectively were jointly inspected and approved by Drug inspectors from CDSCO (West zone) and Aurangabad State FDA and expert from CDL Kasauli to receive export NOC,” the company said. The company said that its state-of-the-art automated manufacturing facilities in Aurangabad are dedicated to produce world class high quality injectable products. Wockhardt has entered into an agreement with Russian Direct Investment Fund and Enso Healthcare to manufacture and supply Sputnik V and Sputnik Light vaccines against Covid-19 based on the technology transfer from Gamaleya National Research Institute of Epidemiology and Microbiology, it said.
